APOE and dementia: Strengths of the study include a well‐characterised longitudinal cohort with repeated cognitive assessments and dementia adjudication, genetic data for both APOE and PRS variants, longitudinal follow‐up to enable survival analysis for dementia and cognition, data available on covariates, adjudicated reports of causes of death to control for competing events and a large number of initially healthy elderly participants.